骨髓中介质干细胞通过调节炎症因子IL-11来改善糖尿病和糖尿病纤维化
Li-Lan Huang1, Ji Yang1, Yue-Yuan Hou1
1Department of Nephrology, The Second Hospital Affiliated to Kunming Medical University, Kunming, 650101, China.
Current stem cell research & therapy
|January 6, 2025
概括
介酶干细胞 (MSC) 治疗在糖尿病病 (DN) 中表现有前途. 在小鼠模型中,MSC治疗减少了损伤和纤维化的关键标志物,这表明对DN的治疗效益.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 干细胞生物学 干细胞生物学
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病病 (DN) 是糖尿病的一个主要并发症,其特点是损伤和纤维化.
- 目前对DN的治疗有效性有限,需要探索新的治疗策略.
研究的目的:
- 研究介质干细胞 (MSC) 在治疗糖尿病病 (DN) 中的治疗潜力.
- 探索MSC治疗对DN小鼠模型中IL-11调节的作用.
主要方法:
- 在体内和体外研究中,使用链毒素 (STZ) 诱导 (T1D) 和高脂肪饮食诱导 (T2D) 的小鼠模型.
- 评估血糖,血清尿素,IL-11和纤维化标志物 (原I/III,α-SMA,维丁,FSP-1,E-Cadherin) 通过生物化学测试和西部涂抹.
- 在实验室验证使用小鼠膜上皮细胞.
主要成果:
- 在T1D和T2D小鼠中,MSC治疗显著降低了血糖,血清尿素,IL-11和纤维化标志物.
- 治疗MSC导致E-Cadherin的表达增加,这表明脏功能得到改善,并减少了上皮细胞-介质细胞过渡.
- 在体外实验证实了MSC介导的纤维化通路的抑制.
结论:
- 介质细胞干细胞治疗显示出糖尿病病的显著治疗潜力.
- 通过抑制IL-11和减少纤维化相关标志物,MSC治疗可能会发挥有益作用.
- MSC疗法代表了对DN的有前途的新型治疗策略.
相关概念视频
01:19Mesenchymal Stem Cells
4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
01:23Tissue Renewal without Stem Cells
1.6K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.6K